awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48237799-721839A9-C353-4306-ADB5-7C0A09CB83BC
Q48237799-721839A9-C353-4306-ADB5-7C0A09CB83BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48237799-721839A9-C353-4306-ADB5-7C0A09CB83BC
Prediction of natalizumab anti-drug antibodies persistency.
P2860
Q48237799-721839A9-C353-4306-ADB5-7C0A09CB83BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48237799-721839A9-C353-4306-ADB5-7C0A09CB83BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c9fce84bb1423786209c4c2c5a701750467ca33a
P2860
Extended interval dosing of natalizumab in multiple sclerosis.